BioCentury
ARTICLE | Company News

AcelRx, U.S. Department of Defense neurology news

May 25, 2015 7:00 AM UTC

AcelRx received a $17 million contract from the DoD’s U. S. Army Medical Research and Material Command (USAMRMC) to fund the next 18 months of clinical development of ARX-04, a sublingual formulation...